Inocucor Technologies raising Series B round of up to $12 mln
Montréal agricultural biotechnology company Inocucor Technologies Inc said it is currently completing a Series B financing "on the order of $10 to $12 million." The round, which will follow the top up of Inocucor's Series A in June, will engage venture capital, institutional and family office investors, the company said. It added that the proceeds will be used to open a U.S. commercialization office. Inocucor noted the fundraising with its announcement of the Canadian registration of its first two specialty products for use by farmers and greenhouse growers. Inocucor's backers include Cycle Capital Management.
19 December 2016•4 mins read
